摘要
目的:了解近期我院肾移植患者住院期间免疫抑制剂应用情况。方法:回顾性查阅2004年我院肾移植病历124份,对免疫抑制剂品种及相关费用进行统计,并与2000年结果进行比较分析。结果:患者2004年平均住院费用74462.77元,应用免疫抑制剂平均费用25809.93元,较2000年分别增长75.12%、175.35%;免疫抑制剂费用占总药费的比例平均为61.37%,而2000年为46.4%;免疫抑制剂使用频率2004年排序前3位的品种分别为甲泼尼龙、环孢素A、泼尼松。结论:与2000年相比,2004年我院肾移植患者新型免疫抑制剂应用品种及费用增加,因而寻找更有效、不良反应更少、更价廉的免疫抑制剂治疗方案具有重要意义。
OBJECTIVE： To investigate the recent use of immunosuppressive agents for renal transplantation patients during our hospital. METHODS： Case history of 124 renal transplantation patients in our hospital in 2004 was reviewed ret rospectively, and the categories and the associated costs of immunosuppressive agents were statistically analyzed, which were compared with that of 2000. RESULTS： In 2004, patients＇ mean hospitalization cost was 74 462.77 yuan and mean immunosuppressive agents cost was 25 809.93 yuan, increased by 75.12% and 175.35%, respectively as compared to 2000. Of the total drug costs, the immunosuppressive agents accounted for 61.37% in 2004 and 46.4% in 2000. Dominated the first 3 places in the list of DDDs of immunosuppressive agents in 2004 were Methylprednisolone, ciclosporin A and dehydroeortisone, respectively. CONCLUSIONS： As compared with 2000, the application categories and costs of neotype immunosuppressive agents for renal transplantation patients in our hospital increased in 2004,thus to find a more effective immunosuppressive remedy that of less adverse drug reaction and lower cost is of great significance.
出处
《中国药房》
CAS
CSCD
北大核心
2006年第9期675-677,共3页
China Pharmacy
关键词
肾移植
免疫抑制剂
费用
使用频率
分析
Renal transplantation
Immunosuppressant agent
Costs
Defined daily close
Analysis
